Crossmark

Post-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate combinations as graft-versus-host disease prophylaxis post allogeneic stem cell transplantation from sibling and unrelated donors in patients with acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Crossref DOI link: https://doi.org/10.1038/s41409-024-02284-5

Published Online: 2024-04-13

Published Print: 2024-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nagler, Arnon http://orcid.org/0000-0002-0763-1265
Labopin, Myriam

Swoboda, Ryszard http://orcid.org/0000-0002-5897-3919
Schroeder, Thomas http://orcid.org/0000-0002-1653-7959
Hamladji, Rose-Marie

Griskevicius, Laimonas

Salmenniemi, Urpu

Rambaldi, Alessandro

Mielke, Stephan

Kulagin, Alexander http://orcid.org/0000-0002-9589-4136
Passweg, Jakob http://orcid.org/0000-0001-7092-3351
Luft, Thomas http://orcid.org/0000-0002-0387-1640
Gedde-Dahl, Tobias

Forcade, Edouard http://orcid.org/0000-0002-8873-2868
Helbig, Grzegorz

Stelljes, Matthias

Castilla-Llorente, Cristina

Spyridonidis, Alexandros http://orcid.org/0000-0003-3097-2532
Brissot, Eolia http://orcid.org/0000-0003-4471-418X
Ciceri, Fabio http://orcid.org/0000-0003-0873-0123
Mohty, Mohamad http://orcid.org/0000-0002-7264-808X
License Information

Text and Data Mining valid from 2024-04-13

Version of Record valid from 2024-04-13
More Information

Article History

Received: 22 January 2024

Revised: 7 April 2024

Accepted: 8 April 2024

First Online: 13 April 2024

Competing interests

: The authors declare no competing interests.

: The scientific boards of the ALWP of the EBMT approved this study.

Document is current

Any future updates will be listed below